Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Neuromuscular Manifestations 1Neuromuscular Diseases 1Myasthenia Gravis 1

Interventions

fludarabine 6efgartigimod alfa 6Cyclophosphamide 6ravulizumab 4zilucoplan 2telitacicept 2rozanolixizumab 2Prednisone 2remibrutinib 1iptacopan 1inebilizumab 1bu-zhong-yi-qi-tang 1Walk Test 1Tacrolimus 1Steroids 1Rituximab 1Pyridostigmine Bromide 1Prednisolone 1Mycophenolic Acid 1Diagnostic Self Evaluation 1Cognitive Behavioral Therapy 1Cladribine 1Biomarkers 1Azathioprine 1Alleles 1Adrenal Cortex Hormones 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Myasthenia Gravis × Diagnostic Self Evaluation × Clear all
NCT06866483 2025-03-10

Validation and Scaling of Screening Program for Undiagnosed Myasthenia Gravis-Social Media Campaign Paired With a Self-moderated Assessment

ZS Associates

Recruiting
1,000 enrolled

Myasthenia Gravis, Neuromuscular Diseases, Neuromuscular Manifestations

Data powered by HemOnc (CC BY 4.0) Colophon âš¡